Newsroom
Client news
The latest news from Optimum clients
Weekly round-up
Read Optimum’s round-up for the low-down on client and industry news
Anglonordic Life Science Conference
22nd-23rd April 2026
The latest news from Optimum clients
Read Optimum’s round-up for the low-down on client and industry news
22nd-23rd April 2026
Movers and shakers
For more information about Optimum Strategic Communications, please get in touch.
Evaluate Vantage shares biopharma predictions for 2023
/in Insights2022 | Optimum’s Year in Review
/in Insights, Optimum newsProfessor Melief of ISA Pharmaceuticals awarded 2 prestigious awards at the 37th Society for Immunotherapy of Cancer Annual Meeting
/in InsightsLSX and Jefferies – Insights from the busiest week in European biotech
/in Insights, Optimum newsPanel Summaries from Optimum’s 14th Annual Healthcare Investor Conference 2022
/in Insights, Optimum newsDan Mahony & Gareth Powell – Global healthcare investing: Can hindsight hone the crystal ball for the future? A fireside chat moderated by Amy Brown, Evaluate Vantage
/in Insights, Optimum newsFinancing growth: Walking the tightrope – Annual Healthcare Investor Conference Insight
/in Insights, Optimum newsCan private markets continue to drive development in Life Sciences? – Insights from Optimum’s Healthcare Conference
/in Insights, Optimum newsTop takeaways from Mike Ward’s fireside chat with Werner Lanthaler, CEO of Evotec
/in Insights, Optimum newsAn Overview of Optimum’s 14th Annual Healthcare Investor Conference 2022
/in Insights, Optimum newsA Q&A by Verona Pharma ahead of World Lung Cancer Day
/in InsightsSTORM Therapeutics: 2022 Winner of “Fierce 15”
/in InsightsUse of Inbiomotion’s MAFTEST® leads to huge reduction in breast cancer mortality
/in InsightsThe burden of COPD and potential impact of novel therapeutics by Verona Pharma
/in InsightsA Q&A with Rising Leader Thijs Cohen Tervaert of INKEF
/in Insights